Inefficient codon usage impairs mRNA accumulation: The case of the v-FLIP gene of Kaposi's sarcoma-associated herpesvirus

Journal of Virology

Volumn 89, Issue 14, 2015, Pages 7097-7107

  Bellare, Priya ^a   Dufresne, Andrew ^a   Ganem, Don ^a  

^a NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLICE INHIBITORY PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; VIRUS RNA; CODON; VIRAL FLIP PROTEIN, HUMAN HERPESVIRUS 8; VIRUS PROTEIN;

ARTICLE; CODON USAGE; CONTROLLED STUDY; ENDOTHELIUM CELL; EXPRESSION VECTOR; GENE EXPRESSION; HEK293 CELL LINE; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA STABILITY; RNA TRANSLATION; V FLIP GENE; VIRION; VIRUS GENOME; VIRUS REACTIVATION; BIOSYNTHESIS; CELL LINE; CODON; GENETICS; GROWTH, DEVELOPMENT AND AGING; HOST PATHOGEN INTERACTION; METABOLISM;

HUMAN HERPESVIRUS 8; MAMMALIA;

CELL LINE; CODON; GENE EXPRESSION; HERPESVIRUS 8, HUMAN; HOST-PATHOGEN INTERACTIONS; HUMANS; NF-KAPPA B; RNA STABILITY; RNA, MESSENGER; VIRAL PROTEINS;

EID: 84931023553     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03390-14     Document Type: Article

References (37)

1. Ganem D. 2010. KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine. J Clin Invest 120:939-949. http://dx.doi.org/10.1172/JCI40567.
2. Cai X, Lu S, Zhang Z, Gonzalez CM, Damania B, Cullen BR. 2005. Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells. Proc Natl Acad Sci USA 102:5570-5575. http://dx.doi.org/10.1073/pnas.0408192102.
3. Zhu Y, Haecker I, Yang Y, Gao S-J, Renne R. 2013. γ-Herpesvirusencoded miRNAs and their roles in viral biology and pathogenesis. Curr Opin Virol 3:266-275. http://dx.doi.org/10.1016/j.coviro.2013.05.013.
4. Ballestas ME, Kaye KM. 2011. The latency-associated nuclear antigen, a multifunctional protein central to Kaposi's sarcoma-associated herpesvirus latency. Future Microbiol 6:1399-1413. http://dx.doi.org/10.2217/fmb.11.137.
5. Godden-Kent D, Talbot SJ, Boshoff C, Chang Y, Moore P, Weiss RA, Mittnacht S. 1997. The cyclin encoded by Kaposi's sarcoma-associated herpesvirus stimulates cdk6 to phosphorylate the retinoblastoma protein and histone H1. J Virol 71:4193-4198.
6. Sadler R, Wu L, Forghani B, Renne R, Zhong W, Herndier B, Ganem D. 1999. A complex translational program generates multiple novel proteins from the latently expressed kaposin (K12) locus of Kaposi's sarcomaassociated herpesvirus. J Virol 73:5722-5730.
7. McCormick C, Ganem D. 2005. The kaposin B protein of KSHV activates the p38/MK2 pathway and stabilizes cytokine mRNAs. Science 307:739-741. http://dx.doi.org/10.1126/science.1105779.
8. Thome M, Schneider P, Hofmann K, Fickenscher H, Meinl E, Neipel F, Mattmann C, Burns K, Bodmer JL, Schröter M, Scaffidi C, Krammer PH, Peter ME, Tschopp J. 1997. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 386:517-521. http://dx.doi.org/10.1038/386517a0.
9. Chaudhary PM, Jasmin A, Eby MT, Hood L. 1999. Modulation of the NF-kappa B pathway by virally encoded death effector domainscontaining proteins. Oncogene 18:5738-5746. http://dx.doi.org/10.1038/sj.onc.1202976.
10. Liu L, Eby MT, Rathore N, Sinha SK, Kumar A, Chaudhary PM. 2002. The human herpes virus 8-encoded viral FLICE inhibitory protein physically associates with and persistently activates the Ikappa B kinase complex. J Biol Chem 277:13745-13751. http://dx.doi.org/10.1074/jbc.M110480200.
11. An J, Sun Y, Sun R, Rettig MB. 2003. Kaposi's sarcoma-associated herpesvirus encoded vFLIP induces cellular IL-6 expression: the role of the NF-kappaB and JNK/AP1 pathways. Oncogene 22:3371-3385. http://dx.doi.org/10.1038/sj.onc.1206407.
12. Sun Q, Zachariah S, Chaudhary PM. 2003. The human herpes virus 8-encoded viral FLICE-inhibitory protein induces cellular transformation via NF-kappaB activation. J Biol Chem 278:52437-52445. http://dx.doi.org/10.1074/jbc.M304199200.
13. Guasparri I, Keller SA, Cesarman E. 2004. KSHV vFLIP is essential for the survival of infected lymphoma cells. J Exp Med 199:993-1003. http://dx.doi.org/10.1084/jem.20031467.
14. Grossmann C, Ganem D. 2008. Effects of NFkappaB activation on KSHV latency and lytic reactivation are complex and context-dependent. Virology 375:94-102. http://dx.doi.org/10.1016/j.virol.2007.12.044.
15. Zhao J, Punj V, Matta H, Mazzacurati L, Schamus S, Yang Y, Yang T, Hong Y, Chaudhary PM. 2007. K13 blocks KSHV lytic replication and deregulates vIL6 and hIL6 expression: a model of lytic replication induced clonal selection in viral oncogenesis. PLoS One 2:e1067. http://dx.doi.org/10.1371/journal.pone.0001067.
16. Brown HJ, Song MJ, Deng H, Wu T-T, Cheng G, Sun R. 2003. NF-kappaB inhibits gammaherpesvirus lytic replication. J Virol 77:8532-8540. http://dx.doi.org/10.1128/JVI.77.15.8532-8540.2003.
17. Grundhoff A, Ganem D. 2001. Mechanisms governing expression of the v-FLIP gene of Kaposi's sarcoma-associated herpesvirus. J Virol 75:1857-1863. http://dx.doi.org/10.1128/JVI.75.4.1857-1863.2001.
18. Dittmer D, Lagunoff M, Renne R, Staskus K, Haase A, Ganem D. 1998. A cluster of latently expressed genes in Kaposi's sarcoma-associated herpesvirus. J Virol 72:8309-8315.
19. Sarid R, Flore O, Bohenzky RA, Chang Y, Moore PS. 1998. Transcription mapping of the Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) genome in a body cavity-based lymphoma cell line (BC-1). J Virol 72:1005-1012.
20. Talbot SJ, Weiss RA, Kellam P, Boshoff C. 1999. Transcriptional analysis of human herpesvirus-8 open reading frames 71, 72, 73, K14, and 74 in a primary effusion lymphoma cell line. Virology 257:84-94. http://dx.doi.org/10.1006/viro.1999.9672.
21. Pearce M, Matsumura S, Wilson AC. 2005. Transcripts encoding K12, v-FLIP, v-cyclin, and the microRNA cluster of Kaposi's sarcomaassociated herpesvirus originate from a common promoter. J Virol 79: 14457-14464. http://dx.doi.org/10.1128/JVI.79.22.14457-14464.2005.
22. Cai X, Cullen BR. 2006. Transcriptional origin of Kaposi's sarcomaassociated herpesvirus microRNAs. J Virol 80:2234-2242. http://dx.doi.org/10.1128/JVI.80.5.2234-2242.2006.
23. Low W, Harries M, Ye H, Du MQ, Boshoff C, Collins M. 2001. Internal ribosome entry site regulates translation of Kaposi's sarcoma-associated herpesvirus FLICE inhibitory protein. J Virol 75:2938-2945. http://dx.doi.org/10.1128/JVI.75.6.2938-2945.2001.
24. Doma MK, Parker R. 2006. Endonucleolytic cleavage of eukaryotic mRNAs with stalls in translation elongation. Nature 440:561-564. http://dx.doi.org/10.1038/nature04530.
25. Stemmer WP, Crameri A, Ha KD, Brennan TM, Heyneker HL. 1995. Single-step assembly of a gene and entire plasmid from large numbers of oligodeoxyribonucleotides. Gene 164:49-53. http://dx.doi.org/10.1016/0378-1119(95)00511-4.
26. Smith HO, Hutchison CA, Pfannkoch C, Venter JC. 2003. Generating a synthetic genome by whole genome assembly: phiX174 bacteriophage from synthetic oligonucleotides. Proc Natl Acad Sci USA 100:15440-15445. http://dx.doi.org/10.1073/pnas.2237126100.
27. Brulois KF, Chang H, Lee AS-Y, Ensser A, Wong L-Y, Toth Z, Lee SH, Lee H-R, Myoung J, Ganem D, Oh T-K, Kim JF, Gao S-J, Jung JU. 2012. Construction and manipulation of a new Kaposi's sarcoma-associated herpesvirus bacterial artificial chromosome clone. J Virol 86:9708-9720. http://dx.doi.org/10.1128/JVI.01019-12.
28. Warming S, Costantino N, Court DL, Jenkins NA, Copeland NG. 2005. Simple and highly efficient BAC recombineering using galK selection. Nucleic Acids Res 33:e36. http://dx.doi.org/10.1093/nar/gni035.
29. Myoung J, Ganem D. 2011. Generation of a doxycycline-inducible KSHV producer cell line of endothelial origin: maintenance of tight latency with efficient reactivation upon induction. J Virol Methods 174:12-21. http://dx.doi.org/10.1016/j.jviromet.2011.03.012.
30. Grossmann C, Podgrabinska S, Skobe M, Ganem D. 2006. Activation of NF-kappaB by the latent vFLIP gene of Kaposi's sarcoma-associated herpesvirus is required for the spindle shape of virus-infected endothelial cells and contributes to their proinflammatory phenotype. J Virol 80:7179-7185. http://dx.doi.org/10.1128/JVI.01603-05.
31. Popp MW-L, Maquat LE. 2014. The dharma of nonsense-mediated mRNA decay in mammalian cells. Mol Cells 37:1-8. http://dx.doi.org/10.14348/molcells.2014.2193.
32. van Hoof A, Frischmeyer PA, Dietz HC, Parker R. 2002. Exosomemediated recognition and degradation of mRNAs lacking a termination codon. Science 295:2262-2264. http://dx.doi.org/10.1126/science.1067272.
33. Harigaya Y, Parker R. 2010. No-go decay: a quality control mechanism for RNA in translation. Wiley Interdiscip Rev RNA 1:132-141.
34. Passos DO, Doma MK, Shoemaker CJ, Muhlrad D, Green R, Weissman J, Hollien J, Parker R. 2009. Analysis of Dom34 and its function in no-go decay. Mol Biol Cell 20:3025-3032. http://dx.doi.org/10.1091/mbc.E09-01-0028.
35. Nakamura H, Lu M, Gwack Y, Souvlis J, Zeichner SL, Jung JU. 2003. Global changes in Kaposi's sarcoma-associated virus gene expression patterns following expression of a tetracycline-inducible Rta transactivator. J Virol 77:4205-4220. http://dx.doi.org/10.1128/JVI.77.7.4205-4220.2003.
36. Schoenberg DR, Maquat LE. 2012. Regulation of cytoplasmic mRNA decay. Nat Rev Genet 13:246-259. http://dx.doi.org/10.1038/ni.2222.
37. Glaunsinger B, Ganem D. 2004. Lytic KSHV infection inhibits host gene expression by accelerating global mRNA turnover. Mol Cell 13:713-723. http://dx.doi.org/10.1016/S1097-2765(04)00091-7.